Abcam Stock News

Abcam plc (NASDAQ:ABCM)’s share price traded up 4.9% during mid-day trading on Tuesday . The company traded as high as $22.53 and last traded at $22.51. 8,623 shares traded hands during trading, a decline of 94% from the average session volume of 140,551 shares. The stock had previously closed at $21.45. Several analysts have recently […]

According to new research study, Global Paper Diagnostics Market Research Report 2027 thinks about key breakdowns in the industry with insights about the market drivers and market restrictions. The report illuminates accumulating an all encompassing rundown of factual investigation for

Goldman Sachs Group Inc. bought a new stake in shares of Abcam plc (NASDAQ:ABCM) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 11,256 shares of the companys stock, valued at approximately $214,000. A number of other institutional investors and []

miRNA Sequencing and Assay Market: Overview The increasing cases of various cancer types have created numerous research and development activities. One of these includes the study of micro RNA sequencing and assay by synthesis, the increasing number of ongoing research of

Abcam plc (LON:ABC) shares reached a new 52-week high on Monday . The company traded as high as GBX 1,750 ($22.86) and last traded at GBX 1,691 ($22.09), with a volume of 14384 shares trading hands. The stock had previously closed at GBX 1,687 ($22.04). A number of equities research analysts recently weighed in on []

Abcam plc (NASDAQ:ABCM) has received a consensus rating of Hold from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings []

Industry Insights A report titled, Global Immunohistochemistry Market Outlook 2022 has been recently published by QY Research. The dedicated analysts and researchers have carried out deep-seated research to put forth the present and future scenario of the Immunohistochemistry market. They

This Multiplex Biomarker Imaging market research demonstrates realistic market judgments. Knowing this enables key stakeholders to make better business decisions, such as bringing the proper products to market. It discusses precise customer insight in order to develop technical solutions that

According to the Historical Low Price-Book Screen, a Premium feature of GuruFocus, four stocks with high financial strength and are trading near historical low price-book ratios are Landstar System In

Abcam PLC  shares rose on Monday as the research tools maker said it had struck a deal to acquire BioVision Inc, a subsidiary of chemicals firm Chinese firm NKY Medical Holdings, for US$340mln in cas

Abcam plc (NASDAQ: ABCM) has agreed to acquire BioVision Inc, a wholly-owned Boai NKY Medical Holdings Ltd subsidiary, for $340 million in cash. The Milpitas, California-based BioVision is a dist

CAMBRIDGE, United Kingdom, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Abcam plc (AIM LSE: ABC; Nasdaq: ABCM) ("Abcam", “the Company” or "the Group"), a global leader in the supply of life science research

ABCM, CCJ, EBMT, MRTN and NESR have been added to the Zacks Rank #5 (Strong Sell) List on July 29, 2021.

Proteomics International Laboratories Ltd (ASX:PIQ) has engaged global life science company Abcam plc (LON:ABC) (OTCMKTS:ABCZF) to manufacture reagents for the immunoassay version of its PromarkerD pr

CAMBRIDGE, July 13, 2021 /PRNewswire/ -- Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA.  The